Difference between revisions of "Zibat A, et al. Oncogene (2010) cited as Ref 228 in DOI: 10.1038/s41392-020-0110-5 (Q9491)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 29, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma, #quickstatements; #temporary_batch_1590010982689) |
||
| Property / title | |||
| + | Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma (English) | ||
| Property / title: Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma (English) / rank | |||
| + | Normal rank | ||
Revision as of 21:55, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Zibat A, et al. Oncogene (2010) cited as Ref 228 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Zibat A
0 references
2010
0 references
Oncogene
0 references
29
0 references
Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma (English)
0 references
